1-丁基-3-甲基咪唑鎓2-(2-甲氧基乙氧基)乙基硫酸酯盐 | 595565-54-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 1-丁基-3-甲基咪唑鎓2-(2-甲氧基乙氧基)乙基硫酸酯盐
• 英文名称: 1-Butyl-3-methylimidazolium 2-(2-methoxyethoxy)ethyl sulfate
• 英文别名: 1-butyl-3-methylimidazol-3-ium;2-(2-methoxyethoxy)ethyl sulfate
• CAS: 595565-54-1
• 化学式: C13H26N2O6S
• 分子量: 338.42
• InChiKey: BSQPRRIYLXHOGO-UHFFFAOYSA-M

物化性质

• 密度：
  1.192 g/mL at 20 °C

计算性质

• 辛醇/水分配系数(LogP)：
  0.24
• 重原子数：
  22
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.77
• 拓扑面积：
  102
• 氢给体数：
  0
• 氢受体数：
  6

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36
• 危险类别码：
  R36/37/38

文献信息

• Method of preparation of halogen-free ionic liquids and ionic liquids prepared in this manner
  申请人：Cassol Claudia Cristiana

  公开号：US20080045723A1

  公开（公告）日：2008-02-21

  The reaction of N-alkylimidazol with alkyl sulfonates, at room temperature, favors the production of 1,3-dialkylimidazolium alkane-sulfonates as crystalline solids at high yields. The alkane-sulfonate anions may be easily substituted by a series of other anions [BF 4 , PF 6 , PF 3 (CF 2 CF 3 ) 3 , CF 3 SO 3 and (CF 3 SO 2 ) 2 N] through simple anion, salt, or acid reactions in water at room temperature. The extraction with dichloromethane, filtration, and evaporation of the solvent, allows the production of the desired ionic liquids at a yield of 80-95%. The purity of these ionic liquids (in some cases >99.4%) is performed using the intensity of 13 C satellite signals from the magnetic resonance spectrums of the N-methyl imidazolium group as an internal standard.

  N-烷基咪唑与烷基磺酸盐在室温下反应，有利于高产率地生成1,3-二烷基咪唑烷磺酸盐作为结晶固体。烷磺酸盐阴离子可以通过简单的阴离子、盐或酸反应在室温下在水中轻松被一系列其他阴离子[BF 4 , PF 6 , PF 3 (CF 2 CF 3 ) 3 , CF 3 SO 3 和(CF 3 SO 2 ) 2 N]所取代。用二氯甲烷萃取、过滤和溶剂蒸发，可以以80-95%的产率生产所需的离子液体。这些离子液体的纯度（在某些情况下>99.4%）是通过使用N-甲基咪唑基团的 13 C卫星信号强度作为内部标准来进行的。
• [EN] PROCESSES FOR THE PREPARATION OF ARTEMISININ AN ITS PRECURSORS<br/>[FR] PROCÉDÉ DE PRÉPARATION D'ARTÉMISININE ET DE SES PRÉCURSEURS
  申请人：AMYRIS BIOTECHNOLOGIES INC

  公开号：WO2009088404A1

  公开（公告）日：2009-07-16

  The present invention provides processes for the preparation of artemisinin and its precursors including amorphadiene, amorphadiene epoxide, dihydroartemisinic alcohol and dihydroartemisinic acid. Specifically, artemisinin is prepared by multi-step synthetic processes from amorphadiene, amorphadiene epoxide, dihydroartemisinic alcohol or dihydroartemisinic acid. Processes for the preparation of amorphadiene, amorphadiene epoxide, dihydroartemisinic alcohol and dihydroartemisinic acid are also disclosed.

  本发明提供了制备青蒿素及其前体的方法，包括阿莫菲二烯、阿莫菲二烯环氧化物、二氢青蒿醇和二氢青蒿酸。具体来说，青蒿素通过从阿莫菲二烯、阿莫菲二烯环氧化物、二氢青蒿醇或二氢青蒿酸进行多步合成过程而制备。还公开了制备阿莫菲二烯、阿莫菲二烯环氧化物、二氢青蒿醇和二氢青蒿酸的方法。
• Arylamine processes
  申请人：Coggan A. Jennifer

  公开号：US20070100164A1

  公开（公告）日：2007-05-03

  A process for the preparation of the tertiary arylamine compound, comprising reacting and arylhalide, such as am arylbromide, and an arylamine in an ionic liquid in the presence of a catalyst.

  一种制备三芳基胺化合物的方法，包括在催化剂存在下，在离子液体中反应芳基卤化物，如芳基溴化物，和芳胺。
• Processes for the Preparation of 2-(1-Phenylethyl)isoindolin-1-one Compounds
  申请人：Frank Anthony J.

  公开号：US20110087033A1

  公开（公告）日：2011-04-14

  Methods for preparation of isoindolin-1-one compounds are described.

  本文描述了制备异吲哚啉-1-酮化合物的方法。
• [EN] ESLICARBAZEPINE ACETATE AND ITS POLYMORPHS<br/>[FR] ACÉTATE D'ESLICARBAZÉPINE ET SES POLYMORPHES
  申请人：REDDYS LAB LTD DR

  公开号：WO2011091131A2

  公开（公告）日：2011-07-28

  Processes for the preparation of eslicarbazepine acetate and intermediates thereof. Also provided are polymorphic forms of eslicarbazepine acetate and methods for their preparation.

  制备艾司卡巴嗪乙酸酯及其中间体的过程。还提供了艾司卡巴嗪乙酸酯的多态形式及其制备方法。